JohnLeonardReaganMD

PubMed

• 141 citations
  Increased incidence of non-Hodgkin lymphoma, leukemia, and myeloma in patients with diabetes mellitus type 2: a meta-analysis of observational studies.
  Jorge J. Castillo, Nikhil Mull, John L. Reagan, Saed Nemr, Joanna Mitri
  Blood. 2012-05-24
• 11 citations
  Clinical features and survival of patients with T-cell/histiocyte-rich large B-cell lymphoma: analysis of the National Cancer Data Base.
  Thomas A Ollila, John L. Reagan, Adam J. Olszewski
  Leukemia & Lymphoma. 2019-07-09
• 93 citations
  Obesity but not overweight increases the incidence and mortality of leukemia in adults: A meta-analysis of prospective cohort studies
  Jorge J. Castillo, John L. Reagan, Randall R Ingham, Michael Furman, Samir Dalia
  Leukemia Research. 2012-07-01

Abstracts/Posters

• Bendamustine-Rituximab Does Not Improve Survival over Rituximab Monotherapy for Older Patients with Nodal or Splenic Marginal Zone Lymphoma
  John L. Reagan, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
• Tumor-Specific Cell-Free DNA (cfDNA) in the Cerebrospinal Fluid (CSF) Detects Cytologically Occult Central Nervous System (CNS) Involvement in Aggressive Lymphomas
  John L Reagan, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
• Comparative Effectiveness of Lenalidomide, Bortezomib, and Their Combinations As First-Line Treatment of Older Patients with Myeloma
  John L. Reagan, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
• Evaluating the Incidence of Cardiovascular and Thrombotic Events in Secondary Polycythemia
  John L Reagan, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Survival Benefits from Antifungal Prophylaxis and a Dedicated Inpatient Malignant Hematology Service during Induction Chemotherapy for Acute Myeloid Leukemia
  John L. Reagan, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
• BrUOG 345: Fractionated Gemtuzumab Ozogamicin Followed By Non-Engraftment Donor Leukocyte Infusions for Relapsed/Refractory Acute Myeloid Leukemia
  John L Reagan, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Join now to see all

Lectures

• Loss of Abelson Interactor-1 Is Linked to Inflammatory Hematopoiesis and Accelerated Aging of Hematopoietic System 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
• Outcomes Associated with Antimicrobial Use during High Dose Cytarabine Consolidation in Acute Myeloid Leukemia 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018